Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The
estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among …

Alcohol-related liver disease (ALD) is a major cause of advanced chronic liver disease in
Latin-America, although data on prevalence is limited. Public health policies aimed at …

Purpose of review To assess the current challenges regarding liver diseases, including the
burden of disease, access to care, screening, and treatment needs in Latin America. Recent …

Background Large medical centers in urban areas, like Los Angeles, care for a diverse
patient population and offer the potential to study the interplay between genetic ancestry and …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, with
increasing prevalence worldwide. The genetic and molecular background of NAFLD …

The small intestine provides the major site for the absorption of numerous orally
administered drugs. However, before reaching to the systemic circulation to exert beneficial …

The gut microbiome plays a key role in the health-disease balance in the human body.
Although its composition is unique for each person and tends to remain stable throughout …

Liver disease from excessive alcohol consumption is an important cause of morbidity and
mortality worldwide. Fermented beverages were first made in the Neolithic era (10,000 BC) …

Introduction and aim Studies have shown that two polymorphisms were associated with
steatosis and progression of non-alcoholic fatty liver disease (NAFLD) in different …

Abstract Treatment outcomes between FOLFIRINOX (5-fluorouracil, leucovorin, irinotecan,
and oxaliplatin) and GNP (gemcitabine with albumin-bound paclitaxel) as first-line …